Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03804996 |
| Title | Study of TG-1801 in Subjects With B-Cell Lymphoma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | TG Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| TG Therapeutics Investigational Trial Site | Heidelberg | Victoria | 03084 | Australia | Details | |
| TG Therapeutics Investigational Trial Site | Melbourne | Victoria | Australia | Details | ||
| TG Therapeutics Investigational Trial Site | Nedlands | Western Australia | 06009 | Australia | Details |